Nicola Fini
University of Modena and Reggio Emilia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nicola Fini.
Epilepsia | 2006
Stefano Meletti; Laura Tassi; Roberto Mai; Nicola Fini; C. A. Tassinari; Giorgio Lo Russo
Summary: Purpose: To assess the quality and frequency of emotions induced by intracerebral electrical stimulation of the temporal lobe.
Epilepsia | 2005
C. A. Tassinari; Laura Tassi; Giovanna Calandra-Buonaura; Michelangelo Stanzani-Maserati; Nicola Fini; Fabio Pizza; Ivana Sartori; Roberto Michelucci; Giorgio Lo Russo; Stefano Meletti
Summary: Purpose: To describe the semiologic features of aggressive behaviors observed in human epileptic seizures with particular reference to the act of biting a conspecific.
Amyotrophic Lateral Sclerosis | 2014
Jessica Mandrioli; Sara Biguzzi; Carlo Guidi; Elisabetta Venturini; Elisabetta Sette; Emilio Terlizzi; Alessandro Ravasio; M. Casmiro; Fabrizio Salvi; Rocco Liguori; R. Rizzi; Vladimiro Pietrini; Elisabetta Chierici; Mario Santangelo; Enrico Granieri; Vittoria Mussuto; Annamaria Borghi; Rita Rinaldi; Nicola Fini; Eleni Georgoulopoulou; Silvia de Pasqua; Marco Vinceti; Francesca Bonvicini; Salvatore Ferro; Roberto D’Alessandro
Abstract Our objective was to describe incidence and clinical features of ALS from a prospective population-based study in Emilia Romagna Region (ERR). From 2009 onwards, a prospective registry recorded all incident cases of ALS among residents in the ERR (population, 4.4 million inhabitants), involving 17 neurological departments. For each patient, detailed demographic and clinical information was collected by caring physicians. Results showed that from 1 January 2009 to 31 December 2011, 347 patients received a new diagnosis of ALS with a crude incidence rate of 2.63/100,000/year. There was micro-geographic heterogeneity throughout ERR, with higher incidence rates in the low density population (3.27/100,000) (p < 0.01). ALS patients have been more frequently employed in agriculture than the general ERR population (8.64% vs. 4.6%, p < 0.01). Clinical features were similar to those described in previous population based studies. In conclusion, we report incidence rates similar to those reported by European registries, reflecting good accuracy of our prospective study. We confirmed previous studies reporting higher incidence rates in rural areas and among agricultural workers. Although genetics has been gaining increasing importance in ALS aetiology, some epidemiological data are still unexplained. Identifying geographical areas or populations with high incidence rates can be a starting point for identifying environmental risk factors. Further studies having this specific aim can shed light on these topics.
Amyotrophic Lateral Sclerosis | 2013
Eleni Georgoulopoulou; Nicola Fini; Marco Vinceti; Marco Monelli; Paolo Vacondio; Giorgia Bianconi; Patrizia Sola; Paolo Nichelli; Jessica Mandrioli
Abstract The prognostic role of riluzole, enteral nutrition (EN), non-invasive ventilation (NIV) and interdisciplinary care in ALS is still debated. A population based study has been performed focusing on ALS survival, with particular attention to prognostic factors and therapeutic intervention. All patients diagnosed with ALS between 2000 and 2009 and residing in Modena, Italy, have been registered. A centre for motor neuron disease (MND) has been active in our province since 2000, in addition to a prospective registry collecting all incident cases. One hundred and ninety-three incident cases have been collected during the 10 years of the study. Results demonstrated that median survival was 41 months (the overall three-year and five-year survival rates being 54.36% and 28.81%, respectively). Based on univariate analysis, factors related to survival were: age at diagnosis, gender, site of onset, phenotype, riluzole treatment and tracheostomy. In the Cox multivariable model, the factors independently related to a longer survival were age (p < 0.01), site of onset (p = 0.02) and riluzole treatment (p < 0.01), with a median gain in survival of 29 months (patients aged < 55 years compared with patients ≥ 55 years), 20 months (spinal versus bulbar onset), and 12 months (riluzole, yes vs. no), respectively. In conclusion, the study has confirmed the prognostic role of clinical features, but has surprisingly demonstrated that riluzole prolonged life significantly longer than NIV and EN. This observational study described the effects of ALS management in a setting that may approximate routine clinical practice more closely than randomized controlled trial (RCT); effects of uncontrolled potential confounders, however, cannot be excluded.
Respirology | 2016
Riccardo Fantini; Jessica Mandrioli; Stefano Zona; Federico Antenora; Andrea Iattoni; Marco Monelli; Nicola Fini; Roberto Tonelli; Enrico Clini; Alessandro Marchioni
Evaluation of diaphragm function in Amyotrophic Lateral Sclerosis (ALS) is critical in determining when to commence non‐invasive mechanical ventilation (NIV).
Muscle & Nerve | 2014
Nicola Fini; Eleni Georgoulopoulou; Marco Vinceti; Marco Monelli; Giovanni Pinelli; Paolo Vacondio; Michele Giovannini; Rossano Dallari; Andrea Marudi; Jessica Mandrioli
Introduction: We performed a population‐based study to assess amyotrophic lateral sclerosis (ALS) survival after noninvasive ventilation (NIV), invasive ventilation (IV), and enteral nutrition (EN). Methods: We included patients diagnosed from 2000 to 2009 in Modena, where a prospective registry and a Motor Neuron Diseases Centre have been active since 2000. Results: Of the 193 incident cases, 47.7% received NIV, 24.3% received tracheostomy, and 49.2% received EN. A total of 10.4% of the patients refused NIV, 31.6% refused IV, and 8.7% refused EN. The median survival times after NIV, IV, and EN were 15, 19, and 9 months, respectively. Of the tracheostomized patients, 79.7% were discharged from the hospital; 73.0% were discharged to home. The median survival times for tracheostomized patients who were cared for at home and in nursing homes were 43 and 2 months, respectively. The multivariate analysis demonstrated that the place of discharge was the only independent prognostic factor after IV (P < 0.01). Conclusions: Service organizations may promote adherence to NIV, IV, EN, and influence postprocedure survival. These data may be useful in defining health plans regarding advanced ALS care and in patient counseling. Muscle Nerve 50: 508–516, 2014
Journal of Trace Elements in Medicine and Biology | 2017
Marco Vinceti; Tommaso Filippini; Jessica Mandrioli; Federica Violi; Annalisa Bargellini; Jennifer Weuve; Nicola Fini; Peter Grill; Bernhard Michalke
Exposure to neurotoxic chemicals such as pesticides, selenium, and heavy metals have been suggested to play a role in the etiology of amyotrophic lateral sclerosis (ALS). We assessed exposure to lead, cadmium, and mercury in 38 ALS patients (16 men and 22 females) and 38 hospital-admitted controls by using their cerebrospinal fluid (CSF) content as biomarker. We determined CSF heavy metal levels with inductively coupled plasma sector field mass spectrometry, according to a methodology specifically developed for this biological matrix. ALS patients had higher median values for Pb (155 vs. 132ng/L) but lower levels for Cd (36 vs. 72ng/L) and Hg (196 vs. 217ng/L). In the highest tertile of exposure, ALS odds ratio was 1.39 (95% CI 0.48-4.25) for Pb, 0.29 (0.08-1.04) for Cd and 3.03 (0.52-17.55) for Hg; however, no dose-response relation emerged. Results were substantially confirmed after conducting various sensitivity analyses, and after stratification for age and sex. Though interpretation of these results is limited by the statistical imprecision of the estimates, and by the possibility that CSF heavy metal content may not reflect long-term antecedent exposure, they do not lend support to a role of the heavy metals cadmium, lead and mercury in ALS etiology.
Amyotrophic Lateral Sclerosis | 2017
Marco Vinceti; Carlotta Malagoli; Sara Fabbi; Leeka Kheifets; Federica Violi; Maurizio Poli; S. Caldara; Daniela Sesti; Silvia Violanti; Paolo Zanichelli; Barbara Notari; Roberto Fava; Alessia Arena; Roberta Calzolari; Tommaso Filippini; Laura Iacuzio; Elisa Arcolin; Jessica Mandrioli; Nicola Fini; Anna Odone; Carlo Signorelli; Francesco Patti; Mario Zappia; Vladimiro Pietrini; Paola Oleari; Sergio Teggi; Grazia Ghermandi; Angela Dimartino; Caterina Ledda; C Mauceri
Abstract The aetiology of amyotrophic lateral sclerosis (ALS), a rare and extremely severe neurodegenerative disease, has been associated with magnetic fields exposure. However, evidence for such a relation in the general population is weak, although the previous null results might also be due to exposure misclassification, or a relationship might exist only for selected subgroups. To test such a hypothesis we carried out a population-based case-control study in two Northern and Southern Italy regions, including 703 ALS cases newly diagnosed from 1998 to 2011 and 2737 controls randomly selected from the residents in the study provinces. Overall, we found that a residence near high-voltage power lines, within the corridors yielding a magnetic fields of ≥0.1 μT, was not associated with an excess disease risk, nor did we identify a dose-response relationship after splitting the exposed corridor according to the 0.1, 0.2 and 0.4 μT cut-points of exposure. These results were confirmed taking into account age at onset, period of diagnosis, sex, geographical area, and length of exposure. Overall, despite the residual possibility of unmeasured confounding or small susceptible subgroups not identified in our study, these results appear to confirm that the exposure to magnetic fields from power lines occurring in the general population is not associated with increased ALS risk.
European Journal of Neurology | 2016
Diana Ferraro; D. Consonni; Nicola Fini; Antonio Fasano; C Del Giovane; Jessica Mandrioli
To compare two recently developed staging systems for amyotrophic lateral sclerosis (ALS) [Kings College and Milano‐Torino staging (MITOS) systems] in an incident, population‐based cohort of patients with ALS.
Neuropathology and Applied Neurobiology | 2017
G. De Marco; Annarosa Lomartire; Andrea Calvo; A. Risso; E De Luca; Michael Mostert; Jessica Mandrioli; Claudia Caponnetto; Giuseppe Borghero; Umberto Manera; Antonio Canosa; Cristina Moglia; Gabriella Restagno; Nicola Fini; C. Tarella; M. T. Giordana; Mt Rinaudo; Adriano Chiò
Cytoplasmic accumulation of the nuclear protein transactive response DNA‐binding protein 43 (TDP‐43) is an early determinant of motor neuron degeneration in most amyotrophic lateral sclerosis (ALS) cases. We previously disclosed this accumulation in circulating lymphomonocytes (CLM) of ALS patients with mutant TARDBP, the TDP‐43‐coding gene, as well as of a healthy individual carrying the parental TARDBP mutation. Here, we investigate TDP‐43 subcellular localization in CLM and in the constituent cells, lymphocytes and monocytes, of patients with various ALS‐linked mutant genes.